Aimed Alliance Calls on Institution To Prevent Discrimination of Patients with Non-Small Cell Lung Cancer

By Aimed Alliance on September 30, 2016 Aimed Activity, Op-eds & News Articles, Policymakers, Resources, Value, Value: Policy Activity

Doctor examining a lung radiography Aimed Alliance has urged the Institute for Clinical and Economic Review (ICER) to consider patient-defined value of non-small cell lung cancer treatments and warned against using measurement systems that can lead to discrimination against patients, such as “quality-adjusted life years” or QALYs. To read the press release, click here.